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Introduction
Bcl-xL is an antiapoptotic Bcl-2 family member that is required 
for embryonic development and can contribute to cancer cell 
survival (Letai, 2008; Hardwick and Youle, 2009). The tra-
ditional viewpoint is that anti- and proapoptotic Bcl-2 family 
proteins actively engage each other to determine cell fate after   
a  death  stimulus  (Galonek  and  Hardwick,  2006;  Youle  and 
Strasser, 2008). The best-characterized cell survival activity of 
Bcl-xL is its ability to inhibit Bax-induced pores in the outer 
mitochondrial membrane (Billen et al., 2008). In this manner, 
Bcl-xL prevents release of mitochondrial cytochrome c into 
the  cytoplasm,  where  cytochrome  c  induces  apoptosome   
formation to trigger caspase-dependent death of mammalian cells. 
Attention has been focused on the functional interactions and 
the binding specificities between anti- and proapoptotic Bcl-2– 
related proteins, leading to new therapeutic strategies (Oltersdorf 
et al., 2005).
The  evolutionary  conservation  of  Bcl-2–like  proteins 
cannot be uniformly linked to apoptosis regulation (for ex-
ample, the Bcl-2 homologues of Drosophila melanogaster and 
viruses; Bellows et al., 2002; Graham et al., 2008; Galindo   
et al., 2009). Many other binding partners have been reported 
for human Bcl-xL, linking Bcl-xL to other cellular processes 
including mitochondrial dynamics, energetics, and autophagy 
M
ammalian Bcl-xL protein localizes to the outer 
mitochondrial  membrane,  where  it  inhibits 
apoptosis by binding Bax and inhibiting Bax-
induced  outer  membrane  permeabilization.  Contrary 
to expectation, we found by electron microscopy and 
biochemical  approaches  that  endogenous  Bcl-xL  also 
localized  to  inner  mitochondrial  cristae.  Two-photon 
microscopy of cultured neurons revealed large fluctua-
tions in inner mitochondrial membrane potential when 
Bcl-xL  was  genetically  deleted  or  pharmacologically 
inhibited, indicating increased total ion flux into and 
out of mitochondria. Computational, biochemical, and 
genetic  evidence  indicated  that  Bcl-xL  reduces  futile 
ion flux across the inner mitochondrial membrane to 
prevent a wasteful drain on cellular resources, thereby 
preventing an energetic crisis during stress. Given that 
F1FO–ATP synthase directly affects mitochondrial mem-
brane potential and having identified the mitochondrial 
ATP  synthase    subunit  in  a  screen  for  Bcl-xL–binding 
partners,  we  tested  and  found  that  Bcl-xL  failed  to   
protect  subunit–deficient yeast. Thus, by bolstering 
mitochondrial energetic capacity, Bcl-xL may contribute 
importantly to cell survival independently of other Bcl-2 
family proteins.
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is consistent with the limited reserve capacity of bcl-x–deficient 
neurons and their susceptibility to cell death. This function of 
Bcl-xL involves the mitochondrial F1FO ATP synthase.
Results
Defective control of mitochondrial 
membrane potential in bcl-x– 
deficient neurons
To explore the function of Bcl-xL in healthy neurons, several 
mitochondrial parameters were analyzed by two-photon laser- 
scanning  fluorescence  microscopy,  comparing  control  and 
bcl-x  conditional  knockout  (cKO)  cortical  neuron  cultures 
(Berman et al., 2009). Both unfloxed and bcl-x–floxed litter-
mates  express  neuron-specific  knockin  NEX-Cre  recombi-
nase starting around embryonic day 12 (E12) to delete bcl-x. 
Staining for Cre recombinase serves as a positive marker for 
the survival of bcl-x–deficient (and control unfloxed) corti-
cal neurons (Fig. 1 A; Berman et al., 2009). Mitochondrial 
membrane potential (m) was assessed in immature cortical 
cultures  with  the  potentiometric  dye  tetramethylrhodamine 
methyl  ester  (TMRM;  nonquench  mode),  revealing  higher 
fluorescence intensity in the mitochondria-enriched regions of 
bcl-x knockout cortical neurons (Fig. 1, B and C [left]). This 
is not a result of increased mitochondrial biomass because 
bcl-x–deficient neurons have lower, not higher, mitochondrial 
biomass in these and other cell types based on several criteria   
(Kowaltowski et al., 2002; Berman et al., 2009). Thus, it appears 
that bcl-x deficiency may result in a higher mitochondrial 
membrane potential.
In respiring cells, three direct mechanisms (Fig. 1 D, 
dashed  boxes)  of  proton  flux  across  the  inner  membrane   
(Fig. 1 D, blue arrows) are main determinants of m: (1) the   
ETC, (2) the F1FO ATP synthase, and (3) uncoupling proteins 
or  other  molecularly  undefined  leak  mechanisms  (protons 
not used for ATP synthesis; Nicholls and Ferguson, 2002). 
To further explore these parameters in bcl-x knockout neu-
rons, reactive oxygen species (ROS) production by the ETC 
was assessed in the same mitochondrial areas where TMRM 
was evaluated. Unexpectedly, bcl-x knockout neurons have 
lower mitochondrial ROS. This suggests either a high rate   
of electron flow through the respiratory chain or that bcl-x 
knockout  neurons  are  more  dependent  on  glycolysis  than   
on mitochondrial respiration for energy production (Fig. 1, A 
and B). The same mitochondrial areas of bcl-x knockout neu-
rons have modestly higher mitochondrial NAD(P)H levels, 
which is consistent with an earlier study (Schwartz et al., 
2007). Higher levels of the complex I substrate NADH indi-
cate more than adequate supplies of NADH either because 
the respiratory chain is inactive or other metabolic processes 
are altered, such as decreased anaplerosis (Abramov et al., 
2007; Cheng et al., 2011). However, no inherent defects in 
respiratory  chain  activity  were  detected  when  complexes   
I–IV, II–IV, and IV were assessed by measuring oxygen con-
sumption in isolated brain mitochondria (Fig. S1, A and B). 
The relative contributions of glycolysis versus the mitochon-
drial F1FO ATP synthase to the levels of total cellular ATP 
(Vander Heiden et al., 2001; Levine et al., 2008; Li et al., 
2008). Thus, Bcl-2 proteins may have alternative biochemi-
cal functions independent of their proapoptotic Bcl-2 family 
binding partners, or they may participate in other machineries 
before engaging classical apoptosis.
One nonapoptosis role of Bcl-2 family proteins in mam-
mals and worms is regulation of mitochondrial fission and   
fusion (Karbowski et al., 2006; Berman et al., 2009; Montessuit 
et al., 2010; Hoppins et al., 2011). This role appears to con-
tribute importantly to Bcl-xL–induced mitochondrial localiza-
tion  at  neuronal  synapses,  neuronal  activity,  and  seizure 
behaviors (Fannjiang et al., 2003; Li et al., 2008). However, 
regulation of fission and fusion rates is not sufficient to ex-
plain the ability of endogenous and overexpressed Bcl-xL to 
increase mitochondrial biomass (Berman et al., 2009). There-
fore, we pursued alternative functions of Bcl-xL in mitochondria. 
Consistent with an evolutionarily conserved function, Bcl-2 
family proteins have been linked to control of mitochondrial 
energetics by regulating the voltage-dependent anion channel 
in the outer membrane or the adenine nucleotide transporter 
(ANT)/adenine  nucleotide  carrier  in  the  inner  membrane, 
which are the primary conduits through which ATP and ADP 
are  exchanged  between  the  cytosol  and  the  mitochondrial   
matrix (Vander  Heiden  et  al.,  2001;  Belzacq  et  al.,  2003; 
Cheng et al., 2003). The relative contributions of antiapoptotic 
activity versus alternative functions of Bcl-xL for overall cell 
survival are unclear.
The mitochondrial F1FO ATP synthase synthesizes ATP 
in the mitochondrial matrix using cytosolic ADP and phos-
phate as substrates (Hong and Pedersen, 2004). This process 
requires a potential across the inner mitochondrial membrane 
that is generated by pumping out protons via the electron trans-
port chain (ETC; or respiratory chain) fueled by NADH. Re-
entry of protons into the mitochondrial matrix via the FO ring 
(oligomycin-sensitive fraction) embedded in the inner mem-
brane drives rotation of the central stalk against the catalytic 
F1, a ring of three  and three  subunits (Walker and Dickson, 
2006). In this manner, proton flux through FO is coupled to 
ATP synthesis. Because mitochondrial membrane potential is 
required for essential functions other than ATP synthesis, there 
are alternative strategies for building a potential. Reversal of 
the F1FO ATP synthase hydrolyzes cytoplasmic ATP produced 
by glycolysis, reversing the flow of protons through FO to 
stabilize a potential (Nicholls and Ferguson, 2002; Abramov 
et al., 2007). A membrane potential is also required for mito-
chondrial fusion, and depolarization of the potential leads to 
Parkin-dependent mitophagy (Narendra et al., 2008; Twig et al., 
2008). Although mitochondrial energetics are linked to mito-
chondrial morphology changes, the details are complex (Benard 
and Rossignol, 2008).
By  analyzing  bcl-x–deficient  neurons,  we  uncovered  a 
new function of Bcl-xL. We found that Bcl-xL can localize to the 
inner mitochondrial membrane/matrix, which is contrary to cur-
rent opinion. Importantly, Bcl-xL is required to stabilize the 
membrane potential across the inner mitochondrial membrane. 
By decreasing excess ion flux across the inner mitochondrial 
membrane, Bcl-xL increases overall energetic efficiency, which 265 Bcl-xL regulates mitochondrial energetics • Chen et al.
Berman et al., 2009) did not significantly alter other mitochon-
drial markers (Fig. 2 A).
Immunogold EM was used to more precisely determine 
the  subcellular  localization  of  endogenous  Bcl-xL  in  tissue 
slices of mouse brain hippocampus. Approximately 90% of 
gold-labeled anti–Bcl-xL (BioCarta) is associated with mem-
branes, and at least half of these membranes (54%) can be 
clearly identified as mitochondria (Fig. 2, B and C). Surpris-
ingly, most of the mitochondrial staining was inside mitochon-
dria, where the colabeled ATP synthase  subunit was also 
found (Figs. 2 [B and C] and S2). The frequency of labeled 
mitochondria with inner membrane/matrix Bcl-xL gold label 
(58%) argues strongly against the possibility of contamina-
tion from the outer membrane as a result of edge skimming, 
folding of the slice preparation, or random background. Gold 
particles on mitochondria were also detected in polar clusters 
(Fig. 2 C, arrowheads) and on membranes adjacent to mito-
chondria, possibly marking mitochondrial fission/fusion sites 
or where the outer mitochondrial membrane may be tethered 
to the ER (Fig. 2 C, line arrows), though patchy staining can 
reflect the uneven epitope accessibility in ultrathin cryosections. 
were also similar between bcl-x knockout and control cul-
tures. ATP levels (relative to total protein) were slightly re-
duced in the bcl-x knockout cortical cultures, though this 
was a result in part of 15% lower cell viability compared 
with controls (Fig. S1, C and D). In sum, no defects were de-
tected to explain the altered mitochondrial parameters of bcl-x  
knockout neurons.
Localization of endogenous Bcl-xL includes 
mitochondrial cristae
To pursue the role of Bcl-xL in regulating mitochondrial param-
eters, we determined the subcellular localization of endogenous 
Bcl-xL protein in neurons of the brain. Endogenous Bcl-xL in 
HeLa cells resides predominantly in the cytosol as a homo-
dimer and translocates to mitochondria via its C-terminal trans-
membrane domain after a death stimulus (Jeong et al., 2004). 
However, crude fractionation of mouse cortex suggests that a 
significant proportion of endogenous Bcl-xL localizes to mito-
chondria in the brain (Fig. 2 A), which is consistent with an   
earlier finding (Soane et al., 2008). Deletion of bcl-x (except in 
interneurons and glial cells where NEX-Cre is not expressed; 
Figure  1.  Altered  mitochondrial  parameters  in 
bcl-x–deficient  neurons.  (A)  Immunofluorescence 
microscopy of control (bcl-x
+/flox;NEX
+/cre) and cKO 
(bcl-x
flox/flox;NEX
+/cre) cortical cultures (DIV6) stained 
with anti–cytochrome c (green; 7H8.2C12 [1:80; 
BD] and goat anti–mouse Alexa Fluor 488 [Invitro-
gen]) to detect mitochondria and costained for Cre 
recombinase  (red;  anti-Cre  [1:2,000;  EMD]  and 
Cy3  goat  anti–rabbit  [1:1,000;  Jackson  Immuno-
Research Laboratories, Inc.). Images were captured 
with  a  real-time  camera  (Diagnostic  Instruments, 
Inc.) and a microscope (Eclipse E800; Nikon). Bars,   
4 µm. (B) Summary of mean fluorescence intensities ±   
SEM  from  two-photon  microscopy  images  of  live 
cortical  cultures  recorded  simultaneously  in  three 
channels to assess m (100 nM TMRM), ROS ac-
cumulation (2 µM CM-DCF), and NAD(P)H (intrinsic 
fluorescence) in one mitochondria-enriched ROI per 
cell for multiple cells (control, n = 50; cKO, n = 56) 
from multiple cultures (control, n = 9; cKO, n = 11), 
with each culture prepared from a different embryo. 
a.u.,  arbitrary  unit.  Student’s  t  test  was  used;  *,   
P < 10
6; **, P < 10
10; ***, P < 10
12. (C) Ex-
amples of two-photon microscopy images marking 
example ROI. Fluorescence intensity is scaled with 
pseudocolors (filled arrows). N, nucleus. Bars, 10 µm.   
(D)  A  diagram  of  three  major  determinants  of   
mitochondrial membrane potential (dashed boxes). 
Electron flow from NADH to O2 (red arrow) via the 
ETC complexes (I–IV), proton (H
+) paths across the 
membrane (blue arrows), ATP/ADP + Pi exchange 
via ANT and phosphate carrier (PC; gray arrow), 
and inner mitochondrial membrane (IM) and outer 
mitochondrial membrane (OM). OSCP, oligomycin 
sensitivity–conferring protein.JCB • VOLUME 195 • NUMBER 2 • 2011   266
Biochemical purification of Bcl-xL with inner 
membrane components
The possibility that Bcl-xL regulates mitochondrial membrane 
potential by acting at the inner mitochondrial membrane led us to 
revisit our earlier yeast two-hybrid screen (Chau et al., 2000). 
Seeking to identify prosurvival functions distinct from anti-
apoptotic functions of Bcl-xL in an unbiased screen, the BH1 do-
main mutant of Bcl-xL (mt1; F131V/D133A), which inhibits cell 
death  without  binding  prodeath  family  members  Bax  or  Bak 
(Cheng et al., 1996), was used to screen a human B cell library 
(Chau et al., 2000). Among the six hits, we identified an unex-
pected Bcl-xL–binding partner, the  subunit of the mitochon-
drial F1FO ATP synthase. This interaction was confirmed in a 
secondary yeast two-hybrid screen in which the  subunit inter-
acted with wild-type Bcl-xL and Bcl-2 but did not interact with 
mutants lacking antideath activity (Bcl-xL mt7 and mt8) and did 
not interact with Bax or Bak (Fig. 3 A). Because Bcl-xL mt1 
could potentially inhibit mammalian cell death by binding BH3-
only proteins (Billen et al., 2008), we assayed the function of 
mt1 and mt8 in yeast, which lack Bcl-2 and BH3-only proteins. 
Bcl-xL mt1 but not mt8 protected yeast from dose-dependent 
cell death (Fig. 3 B).
An  independent  biochemical  purification  scheme  also 
identified the  subunit as the prominent binding partner of 
Importantly, this staining is specific for Bcl-xL based on mul-
tiple parallel preparations of the same brain regions from bcl-x 
cKO mice, in which total anti–Bcl-xL immunogold label was 
reduced by 90%, and mitochondrial Bcl-xL gold was reduced 
99% (Fig. 2, B and D).
To support these findings, protease susceptibility of Bcl-xL 
was  analyzed  in  purified  rat  brain  mitochondria.  Unlike  the 
outer membrane protein Tom20, a portion of Bcl-xL (Abcam 
antibody)  is  resistant  to  proteases  even  after  treatment  with 
digitonin  to  permeabilize  the  cholesterol-containing  outer 
membrane (Fig. 2 E). As expected, matrix-localized  subunit 
was protected from digestion until addition of Triton X-100 to 
disrupt the inner membrane, when both Bcl-xL and  subunit 
were completely digested. The proportion of Bcl-xL protected 
from proteases by the inner membrane can be higher depending 
on the antibody used (Fig. S3). We conclude that a portion of 
endogenous Bcl-xL localizes to the inner mitochondrial mem-
brane and/or matrix. These findings are in sharp contrast to the 
widely held view that Bcl-2 family proteins are localized only 
to the cytoplasmic side of the outer, not inner, mitochondrial 
membranes, though inner membrane localization of Bcl-xL and 
Bcl-2 has been previously reported (Hockenbery et al., 1990; 
Kharbanda et al., 1997; Motoyama et al., 1998; Gotow et al., 
2000; Belzacq et al., 2003).
Figure  2.  Submitochondrial  localization  of 
endogenous Bcl-xL. (A) Immunoblots of total cell 
lysates (clarified), cytosolic fractions, and heavy 
membranes prepared from dissected cortexes 
pooled  from  three  3-d-old  mice  per  sample. 
Blots  were  probed  with  antibodies  to  Bcl-xL 
(1:1,000; provided by L. Boise), cytochrome c  
(Cyt  c;  7H8.2C12  [1:1,000]),  cytochrome 
oxidase subunit IV (COX IV; 1:1,000; Invitro-
gen),  SMAC  (1:1,000;  Invitrogen),  voltage-
dependent  anion  channel  (VDAC;  1:1,000; 
EMD), actin (1:1,000; MP Biomedicals), and 
UCP-2 (6525 [1:100; Santa Cruz Biotechnol-
ogy, Inc.]). A representative of three indepen-
dent  experiments  is  shown.  (B)  Summary  of 
immunogold  EM  staining  for  Bcl-xL  and  ATP 
synthase  proteins in control and cKO mouse 
brain  representing  three  independent  experi-
ments. (C) EM of microdissected CA1 hippo-
campus (where CA1 synapses onto CA3) from 
mouse brains stained with gold-labeled Bcl-xL 
antibody detects Bcl-xL on mitochondrial inner 
membranes/cristae (black arrows), outer mem-
brane polar clusters (arrowheads), and adja-
cent membranes (line arrows). Bars, 0.1 µm.   
(D)  Immunogold  staining  of  bcl-x  cKO  CA1 
mouse brain prepared in parallel as in C. Bar, 
0.1 µm. (E) Immunoblot analysis of Percoll- 
purified nonsynaptic adult rat brain mitochon-
dria.  Mitochondria  were  incubated  with  the 
indicated proteases (for 30 min) with or with-
out 0.01% digitonin to permeabilize the outer 
membrane and were blotted for Bcl-xL (1:1,000; 
Abcam), Tom20 (11415 [1:2,000; Santa Cruz 
Biotechnology, Inc.]), and ATP synthase  sub-
unit (A21351 [1:1,000; Invitrogen]).267 Bcl-xL regulates mitochondrial energetics • Chen et al.
cultured bcl-x knockout and control cortical neurons (Fig. 4 D). 
Although compiled data indicate a small but significant cal-
cium elevation in bcl-x knockout neurons, fluctuations in po-
tential appear not to be controlled by paired fluctuations in 
cytosolic calcium.
To  investigate  the  possibility  that  Bcl-xL  has  a  direct   
role in stabilizing the mitochondrial membrane potential, tetra-
methylrhodamine ethyl ester (TMRE) fluorescence intensity was 
endogenous Bcl-xL. WEHI 7.1 membrane preparations were 
solubilized with CHAPS to avoid detergent-induced dimeriza-
tion with Bax during extract preparation (Hsu and Youle, 1997). 
Bcl-xL–containing complexes were purified by sequential ion 
exchange  and  immunoaffinity  chromatography  followed  by 
preparative SDS-PAGE (Fig. 3 D). The only major Coomassie-
stained species copurifying with Bcl-xL was 54 kD. Direct   
sequencing  of  two  tryptic  peptides  derived  from  this  ex-
tracted band yielded exact matches with the human/mouse F1FO  
ATP synthase -subunit residues 244–253 (NDLYHEMIES) 
and 389–404 (IAELGIYPAVDPLDST).
A screen of 80 detergents yielded a strategy for purifying 
enzymatically active F1FO ATP synthase from mitoplasts iso-
lated from rat liver mitochondria for the purpose of 3D structure 
determination (Ko et al., 2003). Immunoblot analyses of these 
preparations revealed monomeric Bcl-xL, which decreased in 
abundance with purification as a band approximately the size of 
Bcl-xL dimers was enriched with purification (Fig. 3 C). Deter-
gents likely induced SDS-stable dimers of Bcl-xL, which are 
frequently  encountered  with  purified  Bcl-xL  (O’Neill  et  al., 
2006). On parallel blots, both Bcl-xL bands were eliminated 
when the antibody was preadsorbed with recombinant Bcl-xL 
protein, indicating that Bcl-xL is enriched in highly purified 
preparations  of  the  ATP  synthase  from  liver.  To  determine 
whether Bcl-xL is monomeric or present in larger complexes in-
side cells, CHAPS-solubilized lysates were separated by col-
umn chromatography, revealing that all of the Bcl-xL was in 
complexes  >70  kD  that  overlap  fractions  containing  the   
 subunit (Fig. 3 E). An association of Bcl-2 with the F1FO  
ATP synthase  has  also  been  observed  by  the  laboratories   
of J. Downward (London Research Institute, London, England, 
UK), Y. Tsujimoto (Osaka University, Osaka, Japan), and   
S. Korsmeyer and G. Linette (Washington University in St. Louis, 
St. Louis, MO; personal communication).
Membrane potential fluctuations in  
bcl-x–deficient mitochondria
Because the mitochondrial F1FO ATP synthase is an important 
control  point  for  proton  flux  across  the  inner  mitochondrial 
membrane, mitochondrial membrane potential was further evalu-
ated by time-lapse imaging (3.5-s intervals). TMRM intensity 
in mitochondria-enriched regions fluctuates modestly in control 
neurons, which is consistent with an earlier study (Vergun et al., 
2003). However, bcl-x–deficient neurons exhibited a striking 
fluctuation in TMRM fluorescence intensity over irregular   
intervals in time (Fig. 4 A), across a single bcl-x knockout cell 
(Fig. 4 B), and in individual mitochondria (Fig. 4 C). Thus, the 
increase in mean mitochondrial potential in bcl-x–deficient neu-
rons (Fig. 1 B) represents the mean of a time-varying potential 
that fluctuates predominantly to higher (more negative) poten-
tials than controls. Therefore, the presence of Bcl-xL stabilizes 
the inner mitochondrial membrane potential.
Because Bcl-xL can bind to the inositol triphosphate receptor 
in the ER to regulate calcium gating by the inositol triphosphate re-
ceptor (White et al., 2005), we investigated a role for calcium   
in mitochondrial membrane potential fluctuation. We found 
that basal cytosolic calcium levels were uniformly steady in 
Figure  3.  Bcl-xL  association  with  inner  mitochondrial  membrane  com-
ponents.  (A)  Summary  of  yeast  two-hybrid  interactions  between  BCL-2 
family proteins and the ATP synthase  subunit, including wild-type (WT) 
and Bcl-xL mutants mt1 (F131V/D133A), mt7 (V135A/N136I/W137L), 
and mt8 (G138E/R139L/I140N). (B) Yeast (BY4741) transformed with 
the indicated plasmids were heat ramp treated and presented as colony 
counts from four determinations in two independent experiments. Data are 
presented as the mean ± SEM. Student’s t test was used; *, P = 0.012 
compared with control; **, P = 0.001. (C) Immunoblots for Bcl-xL (pro-
vided by L. Boise) or  subunit in total rat liver mitochondria (T), inner 
membrane vesicles (F1), and highly purified ATP synthasomes (F2 and F3) 
of increasing purity (Ko et al., 2003). The replicate blot in the middle was 
probed with Bcl-xL antibody preincubated with recombinant Bcl-xL (rBcl-xL) 
protein purified from Escherichia coli (lanes F1–F3 only). (D) Coomassie 
blue–stained preparative SDS gel of final purification step for Bcl-xL–binding 
partners from WEHI 7.1 cells. (E) Immunoblots for Bcl-xL and  subunit in 
size column chromatography fractions (F) and total lysates (T). Eluted size 
markers are indicated.JCB • VOLUME 195 • NUMBER 2 • 2011   268
maintained by expending energy (Nicolis and Prigogine, 1977). 
Moreover, the additional time-dependent flux of ions across the 
inner membrane that drives these fluctuations in potential can 
result in an overall ion flux (both inward and outward direc-
tions) that is greater than what is required simply to maintain a 
nonfluctuating membrane potential at a steady negative value. 
Thus, the fluctuations in mitochondrial membrane potential in 
bcl-x knockouts imply that more energy is required to maintain 
ion gradients across the inner membrane. To illustrate this con-
cept, we constructed a simple numerical model to investigate 
the effect of fluctuations on the dissipation of ion gradients 
across the mitochondrial membrane. A vesicle (1 µm in diame-
ter) was used to represent a mitochondrion (Fig. 5 A). This ves-
icle was equipped with active ion pumps (Fig. 5 A, b) capable 
of  pumping  out  protons/ions  (approximating  the  respiratory 
chain) to build a negative potential (180 mV) and with ion 
channels (Fig. 5 A, a) that can partially dissipate this poten-
tial by allowing ions to reenter the vesicle (approximating   
the F1FO ATP synthase and nonproductive leaks). We first 
modeled steady-state conditions in which the inward flux and 
monitored in cultured hippocampal neurons treated only briefly 
with ABT-737, a specific inhibitor of Bcl-xL designed to fit the 
binding pocket on Bcl-xL and block its antiapoptotic function 
(Oltersdorf  et  al.,  2005).  Individual  mitochondria  exhibited 
greater fluctuations in TMRE fluorescence intensity after only 
10 min of ABT-737 (in 0.1% DMSO) compared with DMSO 
alone (Fig. 4, E and F). To confirm the specificity of ABT-737, 
hippocampal neurons expressing scrambled or bcl-x–specific 
short hairpin RNA (shRNA) were monitored for TMRE fluores-
cence intensity in time (Fig. S4), and the SD of fluorescence   
intensities was significantly greater for the bcl-x knockdown than 
the control (Fig. 4 G). These data again suggest that Bcl-xL sta-
bilizes the mitochondrial membrane potential by limiting total 
ion flux across the mitochondrial membrane.
Bcl-xL stabilizes the mitochondrial 
membrane potential to conserve energy
It is known that when any chemical system is not at thermo-
dynamic equilibrium, as is the case for respiring mitochondria, the 
occurrence of persistent fluctuations or oscillations can only be 
Figure 4.  Bcl-xL–deficient mitochondria have 
fluctuating membrane potentials. (A) Continu-
ous recordings (3.5-s intervals) of TMRM in-
tensities per ROI of individual cortical neurons 
for at least 250 s (DIV4–5; Fig. 1). Traces are   
representative  of  multiple  neurons  in  three   
independent  experiments.  (B)  Fluorescence 
intensity (arbitrary units [a.u.]) of TMRM stain 
per  pixel  was  determined  for  the  marked   
mitochondria-rich region of a single neuron 
in  bcl-x–deficient  (cKO)  and  control  (Cont) 
cultures shown in Fig. 1 C. (C) SDs were cal-
culated for mean TMRM fluorescence intensi-
ties per pixel for 200 individual mitochondria 
derived from 20 different cells per genotype 
monitored every 2.5 s for at least 90 s. Each 
symbol represents one mitochondrion. An F-test 
for variance comparing control and bcl-x–defi-
cient neuronal mitochondria was performed; P < 
0.0001. (D) Continuous recordings of intracel-
lular calcium levels at 4-s intervals in DIV3–4 
cortical  neurons.  Initial  intracellular  calcium 
levels  from  four  independent  experiments   
are graphed. *, P = 0.039. (E) Mitochondrial 
membrane potential fluctuation increases with 
ABT-737. Fluorescence intensities were mea-
sured  in  small  puncta  (estimated  to  be  one 
mitochondrion) near the soma in cultured rat 
hippocampal  neurons  (DIV14–16)  stained 
with 5 nM TMRE. Relative fluorescence inten-
sities (collected at 1/s) for the same puncta/ 
mitochondria treated with 0.1% DMSO before 
and after addition of 1 µM ABT-737 (in 0.1% 
DMSO) for 10 min are shown. (F) SDs of TMRE 
intensity measurements as in E; data are for 
30 measurements for each of 12 puncta in six 
cells in two independent experiments and are 
similar  to  three  additional  experiments  with 
protocol  variations.  Paired  t  test  was  used; 
*, P = 0.02. (G) SD of TMRE as in F, except 
4 d after transfection with shRNA vector with 
scrambled (n = 10) or bcl-x–specific shRNAs 
(n = 17). Fluorescent images were taken every 
3 s for 8 min. Paired t test was used; **, P = 
0.00027. (F and G) Data are presented as the 
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mitochondrial membrane potential measured over time. A vesicle 
(1.5 µm in diameter) was equipped with a proton pump and a 
proton leak pathway as in Fig. 5 A (a and b). The steady-state 
proton concentration of the mitochondrion was further regulated 
by a fixed proton buffer and a proton–cation exchange pathway 
(Garlid and Paucek, 2003). Finally, we introduced a nonselective 
cation channel representing the one regulated by Bcl-xL, which 
is permeable to both protons and to other cations and has a rever-
sal potential of 0 mV (Lam et al., 1998; Vander Heiden et al., 
2001; Alavian et al., 2011). Opening of the nonselective cation 
channel (mean open time of 0.33 ms) was allowed to occur sto-
chastically with different opening probabilities of 0–0.1. We 
found that opening of the nonselective channel produced fluctua-
tions in the membrane potential that increased with increased 
probability of channel opening (Fig. 5, C and D). The simulation 
further reveals that the very brief increases in internal proton 
concentration produced by influx through the channel resulted in 
proton pump activation, resulting in an overall hyperpolarization 
of the membrane as the frequency of channel openings increased 
(Fig. 5, C and D). This is consistent with transient hyperpolariza-
tion of mitochondria in bcl-x knockout cells as a result of over-
shooting by the respiratory chain after the channel opens.
Draining resources in  
Bcl-xL–deficient neurons
Our vesicle models predict that the increased membrane leaki-
ness (productive and nonproductive ion flux) across the inner 
mitochondrial membrane in bcl-x–deficient neurons will result 
in  decreased  energetic  performance. To  test  this  prediction, 
cultured bcl-x cKO and control cortical neurons were energeti-
cally stressed by the addition of mitochondrial ATP synthase 
inhibitors and analyzed for ATP levels and for mitochondrial 
parameters by two-photon microscopy. Extensive genetic and 
outward flux of ions are exactly matched in time, and the 
membrane potential does not fluctuate in amplitude. These condi-
tions approximate the steady-state conditions of mitochondria in 
wild-type cells. Next, we modeled fluctuations in membrane 
potential by introducing small currents across the vesicle mem-
brane (Fig. 5 A, c). These small currents (set arbitrarily at 5 ms with 
a fixed amplitude between 0 and 10 pA) were allowed to occur 
randomly (averaging 1/s) to drive fluctuations in the potential 
across the vesicle membrane. To assess the effects of these ex-
ternal current amplitudes (Fig. 5 A, c), we measured the magni-
tude of total ion flux through the pumps (Fig. 5 A, a) and the 
channels (Fig. 5 A, b). In all cases, the total amount of ion flux 
(measured in picocoulombs) was increased when current fluc-
tuations were introduced and was further increased with in-
creasing external current amplitude (Fig. 5 B). The additional 
amount of ion movement (Fig. 5 A, a and b) produced by the 
small transient current fluctuations (Fig. 5 A, c) represents a   
futile dissipation of the ion gradient that has to be balanced by 
pump activity to restore the mean membrane potential. Thus, 
Bcl-xL could improve mitochondrial energetics simply by pre-
venting futile ion flux.
Collectively, our results suggest the possibility that Bcl-xL 
regulates an inner mitochondrial membrane ion-conducting 
channel and that this channel has an increased probability of 
opening in the absence of Bcl-xL. This increased channel open-
ing (analogous to point c in Fig. 5 A) could result in the in-
creased membrane potential fluctuations observed in the bcl-x 
knockout. To investigate the effects of such a Bcl-xL–regulated 
channel on mitochondrial membrane potential fluctuations, we 
made a second computational model that more closely repre-
sents known properties of the inner mitochondrial membrane. 
This enabled us to test explicitly the effect of very brief tran-
sient openings of a nonselective inner membrane channel on the 
Figure 5.  Bcl-xL stabilizes the mitochondrial membrane potential to 
conserve energy. (A) A simplified model of ion flux across the inner 
mitochondrial membrane. Ions may enter or leave the matrix through 
leakage channels at point a (e.g., the F1FO ATP synthase through 
which protons enter the mitochondrial matrix), and overall stability 
and membrane potential are maintained by active pumps at point b 
(e.g., the ETC). The double arrow represents the source of fluctuation 
in potential. (B) Numerical simulations of the additional ion flux that 
occurs as a result of fluctuations in membrane potential using the 
1-µm membrane vesicle model in A. An external perturbation with a 
fixed amplitude between 0 and 10 pA (5-ms duration) was allowed 
to occur randomly with a mean interval of 1 s, and the total ion flux 
was integrated over 20-s periods. The graph plots the increase in 
total integrated flux that results from fluctuations of increasing ampli-
tude. (C) Numerical simulations of changes in mitochondrial inner 
membrane potential produced by stochastic opening of a nonselec-
tive cation channel. No openings occur when probability of channel 
opening (Po) equals 0, and the membrane is maintained at a steady 
level (180 mV; dashed lines). Indicated opening rates of the chan-
nel produce fluctuations in membrane potential accompanied by net 
hyperpolarization (more negative potentials). (D) Mean ± SD of mem-
brane potentials for traces in C.JCB • VOLUME 195 • NUMBER 2 • 2011   270
In contrast to controls, bcl-x–deficient cortical neurons 
consistently  underwent  delayed  mitochondrial  depolarization 
30–45 min after the addition of oligomycin (Fig. 6, C and E). 
Consistent with an energy-wasting crisis unique to bcl-x–deficient 
neurons, oligomycin also causes mitochondrial NAD(P)H levels 
to decline to 50% of pretreatment levels in <1 h, whereas 
NAD(P)H levels rebound and stabilize after oligomycin treat-
ment in controls (Fig. 6 F). These results suggest that bcl-x– 
deficient mitochondria continue to deplete the substrate of 
complex I, as would be expected for a leaky mitochondrial mem-
brane that allows the respiratory chain to continue running. 
biochemical evidence indicates that oligomycin inhibits mito-
chondrial ATP synthesis by acting on FO to disrupt the proton 
path (Walker and Dickson, 2006), and a crystal structure re-
veals that aurovertin B inhibits the enzymatic F1 subunit by 
binding  near  the ATP-binding  site  on    subunit  (van  Raaij   
et al., 1996). Treatment with oligomycin or with aurovertin B 
caused cellular ATP levels to decline similarly in control and 
knockout neurons (Fig. 6, A and B). Therefore, the F1FO ATP 
synthase was an important contributor to ATP production and 
concomitant dissipation of membrane potential in both geno-
types before treatment.
Figure 6.  Leaky energetics in Bcl-xL–deficient mito-
chondria. (A and B) Total ATP levels corrected for total 
protein in paired DIV3–6 cortical cultures after addi-
tion of 5 µg/ml oligomycin (control [n = 8] and cKO 
[n = 7] at each of six time points in three independent 
experiments) or 20 µg/ml aurovertin B (control [n = 5]   
and cKO [n = 4] at each of six time points from two 
independent experiments). Vertical dashed lines mark 
the time frame evaluated for TMRM fluorescence in 
C and D. Data are presented as the mean ± SEM.   
(C and D) Time course of TMRM fluorescence intensi-
ties (mean ± SEM) after addition of 5 µg/ml oligo-
mycin. Analyses of 15–35 neurons from three to five 
fields per genotype per time point are presented, and 
results are representative of five similar independent 
experiments.  Parallel  experiments  were  performed 
with 20 µg/ml F1 inhibitor aurovertin B (n = 13–35 
cells from two to three fields at each time point; total 
of 136 control and 193 cKO cells) from two indepen-
dent experiments. (E) Two-photon microscopy images 
of cortical neurons (DIV4) stained with 100 nM TMRM 
to assess m as described for Fig. 1 C after addi-
tion of 6 nM oligomycin (Oligo.). A representative of 
five independent experiments is shown. Bar, 10 µm. 
(F and G) Relative NAD(P)H levels were determined in 
the same cellular subregions analyzed in C and D, as 
described for but not included in Fig. 1 B. Horizontal 
dashed lines mark starting NAD(P)H levels. Data are 
presented  as  relative  ratios  for  direct  comparisons. 
Mean ± SEM is represented, and values are the same 
as in C and D.271 Bcl-xL regulates mitochondrial energetics • Chen et al.
Bcl-xL inhibits mitochondrial  
membrane leakiness
These findings are consistent with a conceptually simple mecha-
nism in which Bcl-xL acts at the inner mitochondrial membrane   
to close a molecularly undefined leak, thereby preventing large   
swings in membrane potential. This could be achieved if Bcl-xL 
directly closes the leak channel. Our computational models   
predict that opening of this Bcl-xL–inhibited leak channel results 
in membrane potential fluctuations, which is consistent with 
fluctuations observed in bcl-x–deficient cells. The models fur-
ther predict that the large fluctuations are a result of transient 
overcompensations by the respiratory chain, which is consis-
tent with the observed transient hyperpolarizations in bcl-x– 
deficient cells. Our numerical simulations also suggest that the 
greater total flux of ions across the mitochondrial inner mem-
brane in bcl-x–deficient mitochondria requires more energy to 
maintain ionic homeostasis, analogous to other fluctuating or 
oscillating biochemical systems (Kaczmarek, 1976). Even if the 
additional ion flux in bcl-x–deficient mitochondria was coupled 
to ATP synthesis by F1FO, additional energy would be required 
to move ions out of the matrix when the potential is fluctuating 
compared with a steady state with little or no fluctuations. 
Our simulations are consistent with the notion that the stabiliz-
ing effect of Bcl-xL on inner mitochondrial membrane potential 
Consistent with this conclusion, rates of oxygen uptake by cells 
decrease with overexpression of Bcl-xL and increase with shRNA 
knockdown of Bcl-xL (Alavian et al., 2011). NAD(P)H deple-
tion and membrane depolarization were not simply a result of 
inhibition of mitochondrial ATP synthesis because NAD(P)H 
levels and membrane potential were sustained for at least 1 h   
after aurovertin B treatment, although at lower steady-state 
levels relative to controls (see Discussion; Fig. 6 G). To verify 
that depletion of NAD(P)H and mitochondrial depolarization 
is not simply a marker of cell death, oligomycin was washed 
away from depolarized bcl-x–deficient neurons in a flow cham-
ber.  Upon  washout,  we  observed  simultaneous  increases  in 
NAD(P)H levels and TMRM intensity, indicating cell recov-
ery (Fig. 7 A). The evidence presented suggests that Bcl-xL in-
creases the efficiency of mitochondrial energetics by decreasing 
inner membrane leakiness, thereby preventing membrane po-
tential fluctuations and the resulting energy deficits (Fig. 7 B).
Bcl-xL requires the  subunit for antideath 
activity in yeast
To test whether Bcl-xL increases cell survival through a func-
tional interaction with F1FO ATP synthase and independently of 
any other Bcl-2 family members, we tested the ability of human 
Bcl-xL to inhibit cell death of yeast lacking  subunit (atp2) of 
the F1FO ATP synthase. Using a novel heat ramp cell death   
assay (Teng et al., 2011), we found that Bcl-xL failed to protect 
yeast in which the ATP2 gene was deleted. In contrast, Bcl-xL 
protected yeast with mutations in both the mitochondrial fission 
protein FIS1 and WHI2, which lack mitochondrial fission and 
have respiratory function defects (fis1*; Figs. 7 C and S5; 
Fannjiang et al., 2004; Cheng et al., 2008). Yeast have no rec-
ognizable Bcl-2 family members or BH3-only proteins yet have 
a highly conserved F1FO ATP synthase. Our results indicate that 
Bcl-xL promotes cell survival through an interaction with the 
ATP synthase.
Discussion
Our evidence indicates that endogenous Bcl-xL prevents a futile 
ion flux across the mitochondrial inner membrane, thereby 
preventing pronounced irregular fluctuations in mitochondrial 
membrane potential observed in bcl-x knockout cells. The ad-
ditional energy required for fueling excessive ion flux across 
the mitochondrial membrane would place bcl-x–deficient cells 
at a distinct disadvantage during cell stress. Unable to sustain 
a potential across a more leaky inner membrane, bcl-x–deficient 
mitochondria  depolarize  and  subsequently  die.  Prominent 
localization of endogenous Bcl-xL with the inner mitochon-
drial membrane is consistent with a close link between Bcl-xL 
and  the  membrane  leak  channels.  Copurification  of  Bcl-xL 
with the F1FO ATP synthase raises the possibility that a novel 
leak channel could be within the ATP synthase itself or a func-
tionally interacting component. This function of Bcl-xL can   
be expected to alter many other aspects of mitochondrial and 
cellular physiology, though, like many mitochondrial pro-
teins, the mechanism by which Bcl-xL enters mitochondria is 
not known.
Figure 7.  Nonapoptotic function of Bcl-xL. (A) Two-photon microscopy of 
bcl-x–deficient cultured neurons was performed as described for Fig. 1 B, 
except using a flow chamber. The measurements shown begin with the 
flow of oligomycin-free medium after 40 min of 5 µg/ml oligomycin (n = 
4–11 per time point per genotype). Data are presented as the mean ± SD. 
(B) A model depicting an increase in membrane leak in the absence of   
Bcl-xL. M, matrix. (C) Heat ramp cell death assay of yeast strains with mutant 
ATP2 or FIS1/whi2-1 (Cheng et al., 2008; Teng et al., 2011). Representa-
tive images of yeast growth are shown; arrows indicate fivefold dilutions. 
Data are presented as mean ± SD for four independent strains per plasmid, 
each tested in duplicate in each of two independent experiments and plot-
ted as the ratio of colony numbers for Bcl-xL/empty vector (FIS1/whi2,   
n = 10; ATP2, n = 16). Student’s t test was used; *, P = 5.7 × 10
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F1Fo ATP synthase. However, the differential effects of two 
F1Fo inhibitors are somewhat puzzling. Both aurovertin B (act-
ing on F1) and oligomycin (acting on FO) block ATPase/syn-
thase activity and proton movement through Fo because of the 
coupling between F1 and Fo. Yet, only aurovertin B inhibited 
mitochondrial depolarization in bcl-x–deficient cells, possibly 
by triggering closure of the leak channel by binding the  sub-
unit (van Raaij et al., 1996). In contrast, the Bcl-xL–regulated 
leak channel appears to be oligomycin resistant, though it is 
not clear whether this is the long sought-after leak channel that   
explains continued mitochondrial respiration with oligomycin 
treatment (Nicholls and Ferguson, 2002). We speculate that the 
F1FO ATP synthase is involved in leaking ions and that the regu-
lation of this function is defective in bcl-x–deficient neurons. 
These studies further extend the long-standing link between 
Bcl-2 family proteins and the ATP synthase (Matsuyama et al., 
1998; Vander Heiden et al., 2001; Belzacq et al., 2003).
Materials and methods
Primary cortical neuron cultures
Conditional bcl-x knockout cortical neuron cultures were prepared sepa-
rately  from  individual  E16.5  mouse  embryos  as  previously  described 
(Berman et al., 2009). Wild-type and floxed bcl-x mice/embryos were 
distinguished using PCR primers 5-GCCACCTCATCAGTCGGG-3 and   
5-TCAGAAGCCGCAATATCCC-C-3. The NEX-CRE locus was identified   
with primers 5-TCTTTTTCATGTGCTCTTGG-3 and 5-CCGCATAACC-
AGTGAAACAG-3,  and  the  wild-type  allele  was  identified  with   
5-CAAGTTGTCCTTCGAGGAAAGAGC-3 and 5-GATACAGACAAG-
AGGGAAGGG-3. All experiments were performed on density-matched 
cultures. All animal procedures were approved by the Animal Care and 
Use Committee. For immunofluorescence microscopy, cortical neuron cul-
tures were quickly washed with Locke’s buffer (154 mM NaCl, 5.6 mM 
KCl, 2.3 mM CaCl2, 1.0 mM MgCl2, 5 mM Hepes, and 10 mM glucose, 
pH 7.4), fixed for 15 min in 4% PFA, permeabilized for 5 min with 0.2% 
Triton X-100, blocked for 30 min at RT with 5% normal goat serum, and 
incubated with primary antibodies at 4°C overnight followed by 1 h at RT 
with secondary antibodies.
Two-photon laser-scanning microscopy
Potentiometric dye TMRM, which accumulates in the matrix according to its 
Nernst potential, was used at 100 nM (the lowest workable concentration; 
nonquench mode verified with carbonyl cyanide-p-trifluoromethoxyphenyl-
hydrazone) to monitor mitochondrial membrane potential m. Accumu-
lation of ROS was monitored simultaneously with 2 µM CM-H2DCFDA 
(5-(-6)-chloromethyl-2’,7’-dichlorohydrofluorescein diacetate). Fluorescence 
probes were loaded into cortical neuron cultures (3–5 days in vitro [DIV3–5]) 
for at least 20 min, and images were recorded using a two-photon   
laser-scanning  microscope  (MRC-1024MP;  Bio-Rad  Laboratories)  with 
an excitation at 740 nm (Tsunami Ti:Sa laser; Spectra-Physics) to measure 
fluorescence intensity of TMRM (605 ± 25 nm), CM-DCF (525 ± 25 nm), 
and intrinsic autofluorescence of endogenous NADH/NADPH (<490 nm;   
Aon et al., 2003). For single recordings, three to five fields per culture dish 
were imaged in immediate succession. For time-lapse recordings, images of 
the same field were captured every 3.5 s for up to 5 min using 50% laser 
intensity to limit photo damage to live samples. Region of interests (ROIs) 
were drawn and analyzed using ImageJ (National Institutes of Health) for 
all neurons per image. Mean fluorescence intensity per pixel in each ROI 
at the three emission wavelengths was calculated as arbitrary fluorescence 
units. Background from cell-free areas was subtracted for each wavelength. 
Photodamage-induced fluctuations specifically in knockout cells is unlikely, 
as fluctuations are evident at the earliest time points and with single-photon 
microscopes (Fig. 4), and treatment with antioxidant N-acetyl cysteine does 
not inhibit depolarization.
Mitochondrial respiration
Mouse forebrain mitochondria were isolated from littermates of control and 
cKO mice (postnatal day 2–7 [P2–P7]) by modification of a standard proto-
col (Rosenthal et al., 1987). Mitochondria (primarily nonsynaptosomal) were 
contributes importantly to the efficiency of energy production. 
An expected negative consequence of excess ion flux is that a 
sudden deficit in nutrients or a sudden increase in energy de-
mand cannot be readily satisfied by an inefficient system.
Seemingly contrary to these findings, recombinant Bcl-xL 
can induce ion channel activity in outer mitochondrial mem-
branes and synthetic bilayers, although these channels are smaller 
than those formed by the related proapoptotic Bax protein (Lam 
et al., 1998; Basañez et al., 2002). Thus, the ion-conducting 
activity of Bcl-xL may not be related to the Bcl-xL functions under 
study here. However, more complex scenarios remain possible 
where Bcl-xL channels open to correct other ion-conducting   
activities  in  the  inner  membrane,  thereby  preventing  large 
swings in potential. Though the detailed molecular events re-
main unclear, our conclusions are supported by patch clamp re-
cordings  of  mitochondrial  inner  membrane  vesicles  with 
Bcl-xL (Alavian et al., 2011). It is conceivable that the Bcl-xL–
inhibited mitochondrial leak channel is related to the Bax pores 
that trigger apoptosis, except Bax pores are not known to occur 
in inner membranes (Billen et al., 2008). The capacity of a non–
Bax/Bak-binding mutant of Bcl-xL (mt1) to interact with the F1 
 subunit and to inhibit cell death in mammalian cells argues 
against this possibility. Furthermore, Bcl-xL can inhibit cell 
death in wild-type yeast, which lack Bcl-2 family and BH3-only 
proteins, but Bcl-xL cannot protect yeast lacking F1 , which 
shares 89% amino acid sequence homology with humans. The 
inner membrane function and the antideath function of Bcl-xL 
appear to be separable biochemical events (e.g., Fig. 7 A). 
However,  yet  unknown  nonapoptotic  activities  of  Bax/Bak 
could be involved, potentially those that regulate neuronal activ-
ity or inhibit neuronal cell death in vivo (Lewis et al., 1999; 
Fannjiang et al., 2003). Furthermore, Bcl-xL was recently re-
ported to regulate acetyl-CoA levels in a Bax/Bak-independent 
manner (Yi et al., 2011).
Given  the  unexpected  finding  that  mitochondrial  ROS 
levels in bcl-x–deficient cells are lower than controls, our data 
are not consistent with Bcl-xL–mediated leak closure serving to 
reduce ROS levels (Jastroch et al., 2010). To the contrary, the 
leakier/fluctuating membrane potential could be expected to   
increase oxygen consumption in bcl-x–deficient cells, which is 
consistent  with  reduced  oxygen  consumption  in  Bcl-xL– 
overexpressing cells (Alavian et al., 2011).
Implications for the F1FO ATP synthase
Because Bcl-xL is not found in the 3D structures of F1Fo ATP syn-
thase, we considered other potential functions for partnering. Given 
a structural resemblance between Bcl-xL and Diphtheria toxin, a 
polypeptide translocator, we considered that Bcl-xL could facilitate 
entry of the  subunit into mitochondria. However, we found that 
bcl-x–deficient mitochondria appear to have normal levels of   
 subunit. Bcl-xL could interact with fully assembled ATP synthase 
or participate in the assembly process, which requires many factors 
not present in active complexes (Rak et al., 2011). Alternatively, the 
effects of Bcl-xL on membrane curvature could influence the ATP 
synthase (Basañez et al., 2002; Paumard et al., 2002).
Our biochemical and pharmacological analyses are con-
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were collected by centrifugation (16,000 g for 10 min at 4°C), and the   
mitochondrial  pellets  were  lysed  in  RIPA  lysis  buffer  (30  mM  Tris-HCl,   
pH 7.4, 0.15 M NaCl, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycho-
late, 1 mM EDTA, 1 mM DTT, and 2 mM MgCl2) containing protease in-
hibitors.  The  sensitivity  of  various  mitochondrial  proteins  to  protease 
digestion was then examined by immunoblot analysis using the following 
antibodies: anti–Bcl-xL (ab2568, 1:1,000; Abcam), anti–cytochrome c 
(clone 7H8.2C12, 1:1,000; Thermo Fisher Scientific), anti-Tom20 (sc-11415, 
1:2,000; Santa Cruz Biotechnology, Inc.), and anti–ATP synthase  subunit 
(1:1,000). The ATP synthasome fractions used are as previously described 
(Ko et al., 2003) and were solubilized in lithium dodecyl sulfate for separa-
tion by SDS-PAGE.
Biochemical purification of Bcl-xL–binding partners
WEHI 7.1 cells (20 ml packed pellet) were lysed in 200 ml of hypo-
tonic buffer (37.5 mM NaCl and 10 mM Hepes, pH 7.4) plus 25 µg/ml 
PMSF using a Dounce homogenizer. The membrane pellet (at 23,000 g for   
30 min) was solubilized in 300 ml of isotonic buffer (150 mM NaCl and 
10 mM Hepes, pH 7.4) plus 1% CHAPS and was clarified by centrifuga-
tion (for 15 min at 15,000 g). The supernatant was loaded onto a 10-ml 
trimethylaminoethyl anion exchange column and washed with 10 column 
volumes of isotonic buffer with 0.5% CHAPS, and bound proteins were 
eluted with a salt gradient (Bcl-xL eluted at 0.35 M NaCl). Bcl-xL–containing 
fractions were immunoaffinity purified with 1 ml anti–murine Bcl-xL anti-
body 7D9 (Hsu et al., 2003) bound to beads (2 mg antibody/ml Seph-
arose beads) for 3 h at 4°C. Beads were washed with isotonic buffer 
with 0.5% CHAPS, and Bcl-xL–containing complexes were eluted with 3 ml   
of 0.1 M acetic acid + 0.3% CHAPS. The sample was neutralized with   
0.4 ml of 1 M Tris (pH 8.0), concentrated (Centricon-30), and separated 
by preparative SDS-PAGE.
Gel filtration of membrane-associated Bcl-xL
10
8 HeLa cells stably expressing Bcl-xL (Hou et al., 2003) were lysed by 
Dounce  homogenization  in  hypotonic  buffer.  The  membrane  pellet  (at 
31,000 g for 30 min) was solubilized in 3 ml of isotonic buffer plus 1%   
CHAPS and clarified by centrifugation (at 31,000 g for 15 min). The   
supernatant (0.4 ml) was loaded onto a 38-ml Superdex 200 gel filtration 
column (GE Healthcare) precalibrated with 67 kD BSA, 45 kD ovalbumin, 
and 24 kD chymotrypsinogen. 0.4-ml column fractions containing Bcl-xL 
were identified by immunoblot analysis with monoclonal 2H12 (Hsu and 
Youle, 1997).
TMRE fluctuation in hippocampal neurons
Dissociated rat hippocampal neurons were prepared from E18 embryos 
and plated on poly-l-lysine–coated dishes in Neurobasal medium with B27 
(Invitrogen; Li et al., 2008). Mature (DIV14–16) cultures were incubated at 
37°C in recording buffer (5 mM KCl, 110 mM NaCl, 2 mM MgCl2, 10 mM 
glucose, 10 mM Hepes, 2 mM CaCl2, pH 7.4, and 310 mOsm) containing 
TMRE (5 nM final). Individual puncta containing mitochondria at the base 
of a dendrite near the soma were outlined and measured by averaging   
4 × 4 pixels as previously described (Li et al., 2008). Fluorescent images 
were collected (1/s for 30 s) with fixed exposure times (300 ms) using an 
inverted microscope (Axiovert 200; Carl Zeiss) with a 63× oil objective. 
Background fluorescence was subtracted for each image, and data were 
analyzed using AxioVision software (version 4.3; Carl Zeiss). For analysis 
of SDs, a straight baseline was subtracted from each graphed line using 
OriginLab 8.0 software to eliminate any artifacts due to slight organelle 
movement during imaging.
Calcium measurement
Mouse  cortical  neurons  (DIV3–5)  grown  on  15-mm  coverslips  were 
loaded with 2 µM cell-permeable Fura-2 acetoxymethyl ester at 37°C for   
30 min, washed with culture medium, and incubated at 37°C for 20–30 min 
to allow complete hydrolysis of acetoxymethyl ester. Coverslips were 
mounted on a AttoFluor system (Carl Zeiss) and continuously infused with 
Locke’s buffer. Cells were sequentially excited at 340 nm/380 nm, and 
fluorescence intensities (510 nm) were determined for individual neurons 
from images captured at 4-s intervals. The 340:380 ratios were con-
verted to nanomoles Ca
2+ using a video imaging system (Intracellular 
Imaging Inc.) and commercial reference standards (Invitrogen) by the 
formula [Ca
2+]i = Kd ([R  Rmin]/[Rmax  R])(Fmax/Fmin), where R equals the 
ratio of 510-nm emission intensities excited at 340 nm relative to 380 nm, 
Rmin equals the ratio at zero free Ca
2+, Rmax equals the ratio at saturating 
Ca
2+ (39 µM), Fmin equals the fluorescence intensity excited at 380 nm 
for zero free Ca
2+, and Fmax equals the fluorescence intensity excited at 
380 nm in saturating Ca
2+.
prepared as previously described for subcellular fractionation and were fur-
ther washed with mannitol sucrose (MS) buffer (without EGTA). Rates of oxy-
gen consumption by purified mitochondria (0.5 mg/ml) were measured with 
a Clark-type oxygen electrode (Hansatech Instruments Limited) in KCl buffer 
(125 mM KCl, 20 mM Trizma base, 2 mM potassium phosphate, and 1 mM 
MgCl2, pH 7.2) plus substrates (Fig. S1 A), 1 mM MgCl2, and 0.25 mM 
EGTA and were calculated in nanomoles of O2 per mg protein per minute 
based on a KCl medium oxygen content of 195 nmol/ml O2 at 30°C.
Crude subcellular fractionation
Cerebral cortexes from P3 mice were rapidly dissected, minced on ice in   
2 ml MS-EGTA buffer (225 mM mannitol, 75 mM sucrose, 250 µM EGTA, 
1 mg/ml fatty acid–free BSA, and 5 mM Hepes, pH 7.4), and homog-
enized with 15 strokes in a 2 ml Dounce. The cortical suspension was 
clarified (at 2,800 g for 3 min at 4°C), and mitochondria were collected 
by centrifugation (15,000 g for 8 min), gently resuspended in MS-EGTA, 
and recentrifuged (for 10 min). The pellet was lysed in 100 µl MS buffer + 1% 
NP-40, and the supernatant was centrifuged at 100,000 g for 30 min to 
clarify the cytosolic fraction.
Immunoblot analyses
Mouse cerebral cortex was dissected on ice and passed 15 times through 
a 25-guage needle in 3 vol of radioimmunoprecipitation assay (RIPA) lysis 
buffer (50 mM Tris, 1% NP-40, 150 mM NaCl, and 1 mM EDTA, pH 7.4) 
plus 1 mM NaF, 1 mM Na3VO4 (sodium orthovanadate and phosphatase 
inhibitor), and protease inhibitors (PMSF, leupeptin, pepstatin, and apo-
protinin). Cultured cortical neurons were washed quickly with Locke’s buf-
fer and lysed in 150 µl of RIPA buffer. 50-µg lysates were separated by 
SDS-PAGE and blotted with specific antibodies (see figure legends).
Immuno-EM
Immunogold labeling of ultrathin cryosections was performed as previously 
described (McCaffery and Farquhar, 1995). Tissues from both genotypes 
were fixed in 4% PFA diluted in PBS, pH 7.4, for 15 min followed by 8% PFA 
for 1 h at RT. Samples were cryoprotected in 2.3 M sucrose plus 20% poly-
vinylpyrrolidone (for 1 h), mounted on aluminum cryopins, and frozen in liquid 
N2. 80-nm ultrathin cryosections cut on a microtome (Ultracut T; Reichert) 
equipped with an FCS cryostage were collected onto 300 mesh formvar/ 
carbon-coated nickel grids. Grids were passed through several drops of PBS 
plus 2.5% FCS and 0.01 M glycine, pH 7.4, blocked in 10% FCS, and incu-
bated overnight with mixed primary antibodies against ATP synthase  sub-
unit (BD) and/or anti–Bcl-xL/S antibody, each at 10 µg/ml. Washed grids 
were incubated for 2 h with one or both secondary antibody gold conjugates 
(1:50; Jackson ImmunoResearch Laboratories, Inc.). Grids were washed sev-
eral times, first with PBS and then with double-distilled H2O. Grids were em-
bedded (3.2% polyvinyl alcohol [molecular mass of 10 kD], 0.2% methyl 
cellulose [400 cps], and 0.2% uranyl acetate) and observed on a transmis-
sion electron microscope (EM 410; Philips Research Eindhoven), and images 
were collected with a digital camera (SIS Megaview III; Olympus). Figures 
were assembled in Photoshop (Adobe) with only linear adjustments in bright-
ness and contrast.
Subfractionation of mitochondria and protease treatment
Nonsynaptic brain mitochondria were isolated from adult male Sprague 
Dawley rats (weights of 300–350 g) by using a Percoll gradient centrifuga-
tion method as previously described (Kristian et al., 2007). In brief, rat 
forebrains were removed and homogenized in isolation medium (225 mM 
mannitol, 75 mM sucrose, 5 mM Hepes, 1 mM EGTA, 225 mM mannitol, 
75 mM sucrose, 5 mM Hepes, and 1 mg/ml fatty acid–free BSA, pH 7.4, 
at 4°C). The resulting homogenate was centrifuged at 1,300 g for 3 min. 
The supernatant containing mitochondria was collected, and the pellet was 
resuspended and recentrifuged at 1,300 g. The pooled supernatants were 
then centrifuged for 10 min at 16,000 g. The crude mitochondrial pellet 
was resuspended in 15% Percoll and layered on top of a 40/20% Percoll 
gradient and then centrifuged for 12 min at 21,000 g. Nonsynaptic mito-
chondria were collected from the interface of the two bottom layers, diluted 
with isolation medium, and centrifuged at 16,000 g for 8 min. The purified 
mitochondrial pellet was resuspended in isolation medium and kept on ice 
until use. Protein concentration of mitochondrial samples was determined 
by using the BCA assay (Thermo Fisher Scientific) and BSA as standards. 
Mitochondrial protease digestion assays were performed by incubating 
freshly isolated mitochondria (1 mg/ml in isolation medium containing   
1 mM MgCl2) for 30 min at 37°C with either 0.2–25 µg/ml Proteinase K 
or 25–200 µg/ml Trypsin. 0.01% digitonin was used to permeabilize the 
outer mitochondrial membrane. The reactions were stopped by addition of a 
protease inhibitor cocktail (Thermo Fisher Scientific), and then mitochondria JCB • VOLUME 195 • NUMBER 2 • 2011   274
atractyloside. Samples were analyzed immediately, or time points were 
frozen  instantly  and  analyzed  together.  Protein  concentration/sample 
(BCA assay) and fresh ATP standards (0, 25 µM, 5 µM, 500 nM, 50 nM, 
and 5 nM) were used to calibrate every experiment.
Yeast cell death assay
Overnight  cultures  of  yeast  strains  (MATa,  his31,  leu20,  met150, 
ura30, and yfg::KanMX4; Invitrogen) transformed with modified pRS-
PGK vector without/with human Bcl-xL were diluted and grown to midlog 
phase (synthetic complete–uracil medium) and plated before and after a 
heat ramp treatment to trigger cell death (30–40°C in 2 min, 40–51°C in 
10 min, and held at 51°C for 5 min; Teng et al., 2011). Both the ATP2 and 
FIS1* knockout strains are more sensitive to cell death than wild type, in 
which Bcl-xL also protects (Fannjiang et al., 2004). For immunoblot analyses, 
lysates were prepared from overnight cultures in lysis buffer (0.05 M Tris-
HCl, pH 7.5, 0.15 M NaCl, 1% NP-40, and 0.1 M PMSF) with glass 
beads and blotted with anti–Bcl-xL (1:5,000 rabbit monoclonal) and anti–
rabbit IgG (1:20,000; GE Healthcare).
Online supplemental material
Fig. S1 shows that no respiratory defects were detected in bcl-x–deficient 
mitochondria. Fig. S2 shows coimmunogold EM for Bcl-xL and F1  subunit. 
Fig. S3 shows protease digestion of mitochondria detected with Bcl-xL anti-
body. Fig. S4 shows an example of TMRE traces and Bcl-xL blots for shRNA 
knockdowns in Fig. 4 G. Fig. S5 shows expression levels of Bcl-xL protein 
in  yeast.  Online  supplemental  material  is  available  at  http://www.jcb 
.org/cgi/content/full/jcb.201108059/DC1.
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Numerical simulations
To estimate the flux of ions in the model vesicle (Fig. 5 A), we integrated 
the equation CdV/dt = Ich + If(t), where V is the membrane potential across 
the vesicle, C represents the capacitance of the vesicle, Ich is the ionic 
current flowing through the channel in the membrane, and If(t) is an addi-
tional fluctuating current that is applied across the membrane. Ich was de-
fined by the equation Ich = gL(V0  V), where gL is the conductance of the 
membrane and, under steady-state conditions, provides a membrane po-
tential of 180 mV (V0 = 180 mV). If(t) was either fixed at 0 or was   
allowed to fluctuate from 0 to a value IFmax for 5-ms periods. These   
fluctuations occurred randomly with a mean period of 1 s. In different 
simulations, the value of IFmax was increased from 0.01 to 10 pA. Equa-
tions were integrated for a time span of 20 s, and the ion flux for the en-
tire period was calculated in picocoulombs. Activity of pumps was not 
simulated explicitly in these models but was incorporated implicitly be-
cause the reversal potential for ion flux (V0 = 180 mV) was held fixed 
during the simulations. Parameters for the simulations were C = 0.314 pico-
farads and gL = 3.14 picosiemens.
For the second model, we tested the effects of a nonselective cation 
channel on the membrane potential across the inner mitochondrial mem-
brane. For simplicity, we included a fixed proton buffer and an electroneu-
tral proton–cation (K
+) exchange pathway (Garlid and Paucek, 2003) such 
that, in the absence of any other channel activity, this model has a steady-
state internal proton concentration of 20 nM (pH 7.7) and a membrane 
potential of 180 mV, as is typical for many mitochondria.
We integrated the following pair of coupled stochastic differential 
equations:
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.	
Ht is the total bound and unbound concentration of protons in the ves-
icle, and V is the voltage across the membrane. Hout is the H
+ concentration 
outside the vesicle and was fixed at 40 nM, whereas Hin, the concentration 
of free protons in the vesicle, was related to the value of Ht and to B, the con-
centration of H
+ buffer in the vesicle, by the following quadratic equation:
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Here, B = 5 × 10
3 mM, and Keq = 2.3 × 10
5 mM.
The constant Av was equal to (1.036 × 10
4)/W, where W is the 
volume of the vesicle (1.767 mm
2). The capacitance of the vesicle C was   
5 × 10
9 nanofarads. The values for gH (the basal proton leak), gL (the 
basal leak of cations), and gCHAN (the conductance of the nonselective 
cation channel) were 5, 5.55 × 10
6, and 5 × 10
4 picosiemens, respec-
tively. The values for kR (the rate constant for H
+ pumping out of the vesicle) 
and kX (the rate of electroneutral cation/H
+ exchange) were 2.5 and 5 × 
10
5 ms
1, respectively.
l(t) is a stochastic function that takes on the value of 1 or 0 depending 
on whether the nonselective cation channel is open or closed. The open prob-
ability, P0, of the channel was determined by the rate constants for channel 
opening (kf) and closing (kb) and was given by the following relation:
	 P
k
k k o
f
f b
=
+
.	
The value of kb was fixed at 0.3 ms
1, which provided a mean open 
time of 3.33 ms. In the simulations of Fig. 5 (C and D), the values of kf were 
set at 0, 0.0005, 0.0101, and 0335 ms
1, providing mean open proba-
bilities of 0, 0.0017, 0.323, and 0.1004.
ATP measurements
Cortical cultures were harvested as for immunoblot analysis plus a phos-
phatase inhibitor; mouse cortex lysates were supplemented with 50 mM 275 Bcl-xL regulates mitochondrial energetics • Chen et al.
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